Questioning the Design of Non-Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III Trials
Clin Pharmacol Ther
.
2025 Jan;117(1):25-27.
doi: 10.1002/cpt.3408.
Epub 2024 Aug 9.
Authors
Florian Lemaitre
1
,
Sébastien Lalanne
2
,
Marie-Clémence Verdier
3
Affiliations
1
Univ Rennes, CHU Rennes, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR S 1085, Rennes, France.
2
INSERM, Centre d'Investigation Clinique 1414, Rennes, France.
3
FHU SUPORT, Rennes, France.
PMID:
39119915
PMCID:
PMC11652807
DOI:
10.1002/cpt.3408
No abstract available